Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

EBMT 2019 | Personalizing survivorship care

Navneet Majhail • 25 Mar 2019
EBMT 2019
General Leukemia Lymphoma Multiple Myeloma

Navneet Majhail, MD, from Cleveland Clinic, Cleveland, OH, emphasizes the importance of personalizing survivorship care according to the patient. Dr Majhail was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

More from Navneet Majhail

Importance of congresses like the EBMT Annual Meeting 1:53
Importance of congresses like the EBMT Annual Meeting
Navneet Majhail • 26 Mar 2019
A Twitter masterclass – how HCPs can benefit from social media platforms 2:02
A Twitter masterclass – how HCPs can benefit from social media platforms
Navneet Majhail • 25 Mar 2019
Transforming healthcare with Twitter: A physician’s perspective 4:12
Transforming healthcare with Twitter: A physician’s perspective
Navneet Majhail • 4 Apr 2016

Related Videos

The FDA approval of daratumumab for high-risk smoldering myeloma based on the AQUILA trial 10:22
The FDA approval of daratumumab for high-risk smoldering myeloma based on the AQUILA trial
Peter Voorhees • 19 Nov 2025
The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
Promising approaches being explored in high-risk myeloma & trials to look out for 2:11
Promising approaches being explored in high-risk myeloma & trials to look out for
Sham Mailankody • 24 Oct 2025
The value of extensive profiling in single-arm trials for high-risk myeloma 2:39
The value of extensive profiling in single-arm trials for high-risk myeloma
Martin Kaiser • 24 Oct 2025
The content of VJHemOnc is intended for healthcare professionals